Dr. Pedro M. Sanz-Altamira
Claim this profileDana Farber-Merrimack Valley
Area of expertise
Breast Cancer
Pedro M. Sanz-Altamira has run 6 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Pedro M. Sanz-Altamira has run 5 trials for Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Dana Farber-Merrimack Valley
Dana-Farber Cancer Instiute - Merrimack Valley
Clinical Trials Pedro M. Sanz-Altamira is currently running
Chemotherapy + Immunotherapy
for Esophageal and Gastric Cancer
This phase III trial compares the effect of modified fluorouracil, leucovorin calcium, oxaliplatin, and irinotecan (mFOLFIRINOX) to modified fluorouracil, leucovorin calcium, and oxaliplatin (mFOLFOX) for the treatment of advanced, unresectable, or metastatic HER2 negative esophageal, gastroesophageal junction, and gastric adenocarcinoma. The usual approach for patients is treatment with FOLFOX chemotherapy. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Fluorouracil stops cells from making DNA and it may kill tumor cells. Leucovorin is used with fluorouracil to enhance the effects of the drug. Oxaliplatin works by killing, stopping, or slowing the growth of tumor cells. Some patients also receive an immunotherapy drug, nivolumab, in addition to FOLFOX chemotherapy. Immunotherapy may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Irinotecan blocks certain enzymes needed for cell division and DNA repair, and it may kill tumor cells. Adding irinotecan to the FOLFOX regimen could shrink the cancer and extend the life of patients with advanced gastroesophageal cancers.
Recruiting
2 awards
Phase 3
2 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting
2 awards
Phase 3
28 criteria
More about Pedro M. Sanz-Altamira
Clinical Trial Related
2 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 9 Active Clinical Trials
Treatments Pedro M. Sanz-Altamira has experience with
- Paclitaxel
- Placebo
- Abemaciclib
- Tamoxifen
- Exemestane
- Trastuzumab
Breakdown of trials Pedro M. Sanz-Altamira has run
Breast Cancer
Lung Cancer
Cancer
Multiple Myeloma
Monoclonal Gammopathy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Pedro M. Sanz-Altamira specialize in?
Pedro M. Sanz-Altamira focuses on Breast Cancer and Lung Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Pedro M. Sanz-Altamira currently recruiting for clinical trials?
Yes, Pedro M. Sanz-Altamira is currently recruiting for 9 clinical trials in Methuen Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Pedro M. Sanz-Altamira has studied deeply?
Yes, Pedro M. Sanz-Altamira has studied treatments such as Paclitaxel, Placebo, Abemaciclib.
What is the best way to schedule an appointment with Pedro M. Sanz-Altamira?
Apply for one of the trials that Pedro M. Sanz-Altamira is conducting.
What is the office address of Pedro M. Sanz-Altamira?
The office of Pedro M. Sanz-Altamira is located at: Dana Farber-Merrimack Valley, Methuen, Massachusetts 01844 United States. This is the address for their practice at the Dana Farber-Merrimack Valley.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.